This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
AstraZeneca to sell $3.5bn of new shares to part fund $6.9bn joint venture with Japan’s Daiichi Sankyo to expand development of trastuzumab deruxtecan cancer treatment ($1.35bn upfront, $5.55 contingent on milestones). FY guidance unchanged, expects benefit to earnings in 2020, with a “significant contribution” in 2023. Placement will also repay $1bn existing debt.
UK Index Housebuilders could benefit from Nationwide House Prices +0.7% YoY beating +0.6% estimate (+0.2% MoM vs. flat est.)
Paddy Power sees Sportsbook revs doubling to $30m in Q1; New Jersey contribution guidance unchanged, positive 18-30 months post-launch; avg 12 month payback on customer investment.
Rio Tinto declares force majeure on some iron-ore contracts after tropical cyclone Veronica hit NW Australia; assessing damage to Cape Lambert A port. Dampier and Cape Lambert B resumed.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| BHP | BHP | 1.7% | 2.1% | 0.9% |
| SSE | SSE | -1.6% | 0.3% | -1.7% |
| JOHNSON MATTHEY | JMAT | 2.5% | 3.6% | 0.7% |
| GULF KEYSTONE PETROLEUM | GKP | -3.3% | 7.6% | -5.6% |
| MITIE | MTO | -5.0% | 1.6% | -8.3% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research